salbutamol 100 mcg

DRUG2 trials

Sponsors

GlaxoSmithKline, Chiesi Farmaceutici S.p.A.

Conditions

AsthmaBronchial Asthma

Phase 3

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

CompletedNCT00528723

Chiesi Farmaceutici S.p.A.Bronchial Asthma

Start: 2007-11-30End: 2009-01-31Target: 180Updated: 2017-03-30

Phase 4

Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data

CompletedNCT00363480

GlaxoSmithKlineAsthma

Start: 2006-05-17End: 2007-09-14Updated: 2018-03-09